AAV-RIPK3 shRNA Interferes With the Expression of RIPK3, Reverses the Dysfunction of Myocardial Hypertrophy, Myocardial Fibrosis, and Inflammation, and Reduces Myocardial Damage. This evidence concerns the gene RIPK3 and Myocardial fibrosis.